共 50 条
Does this optic neuritis patient have neuromyelitis optica? An approach to optic neuritis in the context of neuromyelitis optica
被引:1
|作者:
Burton, Jodie M.
[1
,2
,3
,4
]
Costello, Fiona
[1
,2
,3
,5
]
机构:
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Calgary, AB, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[5] Univ Calgary, Dept Surg Ophthalmol, Calgary, AB, Canada
关键词:
aquaporin-4;
demyelinating disease;
Devic's disease;
immunosuppression;
myelopathy;
neuromyelitis optica;
neuromyelitis optica spectrum disorder;
NMO-IgG;
optic neuritis;
rituximab;
D O I:
10.1586/17469899.2014.922874
中图分类号:
R77 [眼科学];
学科分类号:
100212 ;
摘要:
Optic neuritis is a common presentation of demyelinating disease, most often associated with multiple sclerosis, and typically associated with a relatively good recovery and prognosis. However, when optic neuritis is the heralding event of neuromyelitis optica (NMO), it is much more likely to be the start of a devastating and disabling chronic disease with a reduced lifespan. Early recognition of NMO is the best chance a patient has of avoiding life-altering disability, as relapse prevention is essentially disability prevention because this disease, unlike MS, does not really have a progressive component. The following review was written to assist the clinician, particularly the ophthalmologist, in assessing optic neuritis in evaluating and recognizing the potential NMO patient.
引用
收藏
页码:205 / 216
页数:12
相关论文